Partner Organizations
|
|
Bayer AG, Germany
Computational Molecular Design Scientist-in-Charge: Dr. Linn Schneider |
|
|
Science Communication, Greece
Scientist-in-Charge: Dr. Theodore Anagnostopoulos |
|
|
UCB Biopharma SRL, Belgium
Global CADD Scientist-in-Charge: Dr. Marley Samways, Dr. Silvia Lovera |
|
|
Astex Therapeutics Limited, United Kingdom
Computational Chemistry Scientist-in-Charge: Dr. Reto Walser |
|
|
Gain Therapeutics SA, Spain
Computational Chemistry Scientist-in-Charge: Dr. Elena Cubero |
|
|
Novo Nordisk A/S, Denmark
Modelling & Predictive Technologies Scientist-in-Charge: Dr. Simone Fulle |
|
Institute Pasteur, France
Department of Neurosciences Scientist-in-Charge: Prof. Jean-Pierre Changeux |
|
|
Budapest University of Technology, Hungary
George Olah Doctoral School Scientist-in-Charge: Prof. László Poppe |
|
|
University of Geneva, Switzerland
Computer-aided drug design Scientist-in-Charge: Prof. Francesco L. Gervasio |
|
|
Confo Therapeutics N.V., Belgium
Computer-Aided Drug Design (CADD) Scientist-in-Charge: Dr. Berthold Wroblowski |
|
|
Freie Universitaet Berlin, Germany
Graduate School Prof. Markus Wahl |
|
|
This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956314.
|
|